Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 9/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.49 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.49 |
| ▸ | ROCK2 | O75116 | 6/20 | 0.49 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27195727 | 0.79 | CNR1 (0.53) | TRPV1CNR1NPY5RKDM4EALDH1A1 | |
| SCHEMBL27195713 | 0.78 | HDAC6 (0.60) | TRPV1ROCK2ROCK1CNR1KDM4E | |
| Hydrochloric Acid SCHEMBL30863459 | 0.78 | CNR1 (0.57) | TRPV1LCKKDRCNR1NPY5R | |
| SCHEMBL13763276 | 0.77 | NPY5R (0.57) | TRPV1CNR1NPY5RKDM4EALDH1A1 | |
| SCHEMBL30863517 | 0.76 | CNR1 (0.51) | TRPV1CNR1KDM4EMAPT | |
| SCHEMBL27195745 | 0.76 | CNR1 (0.51) | TRPV1CNR1KDM4EMAPT | |
| SCHEMBL27195735 | 0.76 | CNR1 (0.51) | TRPV1CNR1KDM4EALDH1A1MAPT | |
| SCHEMBL30863450 | 0.75 | TRPV1 (0.57) | TRPV1CNR1NPY5RKDM4EALDH1A1 | |
| SCHEMBL27195688 | 0.75 | TRPV1 (0.57) | TRPV1CNR1NPY5RKDM4EALDH1A1 | |
| SCHEMBL30863515 | 0.74 | TRPV1 (0.59) | TRPV1NPY5RKDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | claimed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | claimed |
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | disclosed |